| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16110-915-30 | 16110-915 | HUMAN PRESCRIPTION DRUG | TAZORAC | tazarotene | CREAM | CUTANEOUS | 20200203 | N/A | NDA | NDA021184 | ALMIRALL, LLC | TAZAROTENE | .05 mg/g | 1 TUBE in 1 CARTON (16110-915-30) / 30 g in 1 TUBE |
| 16110-915-60 | 16110-915 | HUMAN PRESCRIPTION DRUG | TAZORAC | tazarotene | CREAM | CUTANEOUS | 20200203 | N/A | NDA | NDA021184 | ALMIRALL, LLC | TAZAROTENE | .05 mg/g | 1 TUBE in 1 CARTON (16110-915-60) / 60 g in 1 TUBE |
| 16110-916-30 | 16110-916 | HUMAN PRESCRIPTION DRUG | TAZORAC | tazarotene | CREAM | CUTANEOUS | 20200203 | N/A | NDA | NDA021184 | ALMIRALL, LLC | TAZAROTENE | .1 mg/g | 1 TUBE in 1 CARTON (16110-916-30) / 30 g in 1 TUBE |
| 16110-916-60 | 16110-916 | HUMAN PRESCRIPTION DRUG | TAZORAC | tazarotene | CREAM | CUTANEOUS | 20200203 | N/A | NDA | NDA021184 | ALMIRALL, LLC | TAZAROTENE | .1 mg/g | 1 TUBE in 1 CARTON (16110-916-60) / 60 g in 1 TUBE |
| 60758-561-30 | 60758-561 | HUMAN PRESCRIPTION DRUG | Tazarotene | Tazarotene | CREAM | TOPICAL | 20170415 | N/A | NDA AUTHORIZED GENERIC | NDA021184 | Pacific Pharma, Inc. | TAZAROTENE | 1 mg/g | 1 TUBE in 1 CARTON (60758-561-30) / 30 g in 1 TUBE |
| 60758-561-60 | 60758-561 | HUMAN PRESCRIPTION DRUG | Tazarotene | Tazarotene | CREAM | TOPICAL | 20170415 | N/A | NDA AUTHORIZED GENERIC | NDA021184 | Pacific Pharma, Inc. | TAZAROTENE | 1 mg/g | 1 TUBE in 1 CARTON (60758-561-60) / 60 g in 1 TUBE |